Maria Elizabeth Falzone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maria Elizabeth Falzone has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Alessio Accardi
Weill Cornell Medical College
14 shared publications - Alexander Bryan Taylor
Department of Biochemistry & Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
9 shared publications - Benjamin C. Onyeagucha
Mississippi University for Women, Columbus, MS, USA
9 shared publications - Chris T. P. Do
Greehey Children’s Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas
9 shared publications - Daisy Medina
Greehey Children’s Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas
9 shared publications - Daohong Zhou
Department of Biochemistry and Structural Biology, University of Texas Health Science Center, San Antonio, USA
9 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (31)
PLCβs are recruited to the plasma membrane in macrophages by both Gβγ and Gα q
PLCβ enzymes cleave PIP2 from the plasma membrane, producing IP3 and DAG, which regulate intracellular Ca 2+ levels and protein kinase C activity, respectively. They are regulated by GPCR signaling through the G proteins Gβγ and Gα q and have been shown to function as coincidence detectors for dual stimulation of Gα q - and Gα i -coupled receptors via these G proteins. PLCβs are aqueous-soluble enzymes, but partition onto the membrane surface to access their lipid substrate. We previously demonstrated that membrane recruitment and orientation of the catalytic core on the membrane surface underlie Gβγ-dependent regulation of PLCβ enzymes. Using macrophages as a model system, where PLCβ signaling is essential for responses to infection and tissue injury, we investigated the contribution of Gβγ-dependent regulation and membrane recruitment of PLCβ in the context of endogenous signaling. By measuring Ca 2+ mobilization, we demonstrate that both Gα i - and Gα q -coupled receptors independently stimulate PLCβ activity. Using total internal reflection fluorescence and stimulated emission depletion microscopy, we demonstrate that most of the PLCβ3 in the cell is localized away from the plasma membrane at rest but is rapidly recruited to the plasma membrane upon stimulation by both Gα i - and Gα q -coupled receptors, illustrating that both Gβγ and Gα q recruit PLCβ to the plasma membrane. These results support an updated model for G protein–dependent regulation of PLCβ enzymes, where Gβγ-induced regulation in the absence of Gα q can occur and is apparently dictated by the local concentration of receptor, G proteins, and PLCβ.
- 27 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (31)
Open AccessPLCβs are recruited to the plasma membrane in macrophages by both Gβγ and Gα q
PLCβ enzymes cleave PIP2 from the plasma membrane, producing IP3 and DAG, which regulate intracellular Ca 2+ levels and protein kinase C activity, respectively. They are regulated by GPCR signaling through the G proteins Gβγ and Gα q and have been shown to function as coincidence detectors for dual stimulation of Gα q - and Gα i -coupled receptors via these G proteins. PLCβs are aqueous-soluble enzymes, but partition onto the membrane surface to access their lipid substrate. We previously demonstrated that membrane recruitment and orientation of the catalytic core on the membrane surface underlie Gβγ-dependent regulation of PLCβ enzymes. Using macrophages as a model system, where PLCβ signaling is essential for responses to infection and tissue injury, we investigated the contribution of Gβγ-dependent regulation and membrane recruitment of PLCβ in the context of endogenous signaling. By measuring Ca 2+ mobilization, we demonstrate that both Gα i - and Gα q -coupled receptors independently stimulate PLCβ activity. Using total internal reflection fluorescence and stimulated emission depletion microscopy, we demonstrate that most of the PLCβ3 in the cell is localized away from the plasma membrane at rest but is rapidly recruited to the plasma membrane upon stimulation by both Gα i - and Gα q -coupled receptors, illustrating that both Gβγ and Gα q recruit PLCβ to the plasma membrane. These results support an updated model for G protein–dependent regulation of PLCβ enzymes, where Gβγ-induced regulation in the absence of Gα q can occur and is apparently dictated by the local concentration of receptor, G proteins, and PLCβ.
- Open Access
Anionic lipids regulate PLCβ membrane recruitment
Phospholipase C-β (PLCβ) enzymes are essential effectors of G protein-coupled receptor signaling that hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) at the plasma membrane to generate the second messengers inositol trisphosphate and diacylglycerol. PLCβs play essential roles in diverse physiological processes, including cardiac and neuronal function, macrophage activation, and the pathogenesis of diseases such as hypertrophic cardiomyopathy. PLCβ enzymes are unique in that they are aqueous-soluble and must partition onto the membrane surface to access their substrate, making membrane association a critical regulatory step. For example, we recently demonstrated that Gβγ activates PLCβ by membrane recruitment and orientation of the catalytic core on the membrane surface. Although PLCβ membrane recruitment is required for function, the molecular determinants governing this process remain incompletely understood. Using a quantitative membrane partitioning assay, we show that robust membrane association of PLCβ requires anionic phospholipids, whereas polar phospholipids cannot substitute. Membrane partitioning exhibits a steep dependence on anionic lipid abundance, which is mediated by electrostatic interactions between negatively charged lipids and basic residues within the distal C-terminal domain of PLCβ. We further demonstrate that anionic lipids cooperate with Gβγ to regulate PLCβ membrane recruitment, such that the magnitude of Gβγ-dependent recruitment is dictated by membrane anionic lipid content. These findings reconcile previous discrepancies regarding Gβγ-mediated PLCβ membrane recruitment and establish membrane electrostatics as a key regulatory input that integrates lipid composition with G protein signaling to regulate PLCβ activity. Summary: Membrane association is a crucial component of PLCβ function and regulation, yet the mechanisms governing this process are poorly understood. The authors demonstrate that anionic lipids drive PLCβ membrane recruitment and influence Gβγ-dependent activation, revealing how membrane composition shapes cellular signal transduction.
Open AccessAnionic lipids regulate PLCβ membrane recruitment
Phospholipase C-β (PLCβ) enzymes are essential effectors of G protein-coupled receptor signaling that hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) at the plasma membrane to generate the second messengers inositol trisphosphate and diacylglycerol. PLCβs play essential roles in diverse physiological processes, including cardiac and neuronal function, macrophage activation, and the pathogenesis of diseases such as hypertrophic cardiomyopathy. PLCβ enzymes are unique in that they are aqueous-soluble and must partition onto the membrane surface to access their substrate, making membrane association a critical regulatory step. For example, we recently demonstrated that Gβγ activates PLCβ by membrane recruitment and orientation of the catalytic core on the membrane surface. Although PLCβ membrane recruitment is required for function, the molecular determinants governing this process remain incompletely understood. Using a quantitative membrane partitioning assay, we show that robust membrane association of PLCβ requires anionic phospholipids, whereas polar phospholipids cannot substitute. Membrane partitioning exhibits a steep dependence on anionic lipid abundance, which is mediated by electrostatic interactions between negatively charged lipids and basic residues within the distal C-terminal domain of PLCβ. We further demonstrate that anionic lipids cooperate with Gβγ to regulate PLCβ membrane recruitment, such that the magnitude of Gβγ-dependent recruitment is dictated by membrane anionic lipid content. These findings reconcile previous discrepancies regarding Gβγ-mediated PLCβ membrane recruitment and establish membrane electrostatics as a key regulatory input that integrates lipid composition with G protein signaling to regulate PLCβ activity. Summary: Membrane association is a crucial component of PLCβ function and regulation, yet the mechanisms governing this process are poorly understood. The authors demonstrate that anionic lipids drive PLCβ membrane recruitment and influence Gβγ-dependent activation, revealing how membrane composition shapes cellular signal transduction.
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI5 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
Selection of best clones producing functional anti-SCUBE3 antibody
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI5 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
Selection of best clones producing functional anti-SCUBE3 antibody
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI4 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulates MHC class I and class II expression
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI4 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulates MHC class I and class II expression
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI6 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
Intra-tumoral injection of anti-SCUBE3 antibody inhibits tumor growth
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI6 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
Intra-tumoral injection of anti-SCUBE3 antibody inhibits tumor growth
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI2 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 interacts with cell surface receptors
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI2 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 interacts with cell surface receptors
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI1 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulated tumor cell growth
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI1 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulated tumor cell growth
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure SI3 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulates FOXR2 to activate pro-growth signaling
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure SI3 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
SCUBE3 regulates FOXR2 to activate pro-growth signaling